A study reported that the selective 12/15-LOX inhibitor and the pan-LOX inhibitor nordihydroguaiaretic acid protected acute lymphoblastic leukemia (ALL) cells against RLS3-induced ferroptosis (Probst et al., 2017). This evidence concerns the gene LOX and acute lymphoblastic leukemia.